Advertisement
Screener

FORTE BIOSCIENCES, INC. (FBRX) Cash and securities

FORTE BIOSCIENCES, INC. (FBRX) Cash and securities

  • Total cash · latest quarter (USD): Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30..
  • Cash per share · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30..

Cash and securities

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Total cash · latest quarter (USD)(m)Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30.

Calculation unavailable: missing inputs remain (m).

Cash per share · latest quarter(m)Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Cash and equivalents49.63M USDCash and Cash Equivalents, at Carrying Value
Short-term securities(m)Debt Securities, Available-for-sale, Current
Cash and current securities(m)Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current
Quarter-end shares(m)Common Stock, Shares, Outstanding

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingTotal cashCash per shareCash and equivalents (USD)Short-term securities (USD)Quarter-end shares (shares)
2026-06-30(m)(m)$49.63M(m)(m)
2026-03-31(m)(m)$58.22M(m)(m)
2025-12-31(m)(m)$76.96M(m)(m)
2025-09-30(m)(m)$93.41M(m)(m)
2025-06-30(m)(m)$106.14M(m)(m)
2025-03-31(m)(m)$45.86M(m)(m)
2024-12-31(m)(m)$22.24M(m)(m)
2024-09-30(m)(m)$16.36M(m)(m)
2024-06-30(m)(m)$24.50M(m)(m)
2024-03-31(m)(m)$30.44M(m)(m)
2023-12-31(m)(m)$37.13M(m)(m)
2023-09-30(m)(m)$46.19M(m)(m)
2023-06-30$30.43M(m)$20.44M$9.99M(m)
2023-03-31(m)(m)$35.90M(m)(m)
2022-12-31(m)(m)$41.10M(m)(m)
2022-09-30(m)(m)$44.05M(m)(m)
2022-06-30(m)(m)$38.55M(m)(m)
2022-03-31(m)(m)$40.03M(m)(m)
2021-12-31(m)(m)$42.04M(m)(m)
2021-09-30(m)(m)$45.66M(m)(m)
2021-06-30(m)(m)$50.80M(m)(m)
2021-03-31(m)(m)$54.76M(m)(m)
2020-12-31(m)(m)$58.77M(m)(m)
2020-09-30(m)(m)$20.18M(m)(m)
2020-06-30(m)(m)$27.75M(m)(m)
2020-03-31(m)(m)$14.23M(m)(m)
2019-12-31$21.82M(m)$8.99M$12.84M(m)
2019-09-30$55.34M(m)$25.58M$29.76M(m)
2019-06-30$68.32M(m)$18.90M$49.43M(m)
2019-03-31$80.12M(m)$31.00M$49.13M(m)
2018-12-31$96.09M(m)$40.81M$55.27M(m)
2018-09-30$79.85M(m)$23.48M$56.37M(m)
2018-06-30$79.46M(m)$24.61M$54.85M(m)
2018-03-31$74.00M(m)$17.79M$56.20M(m)
2017-12-31$88.72M(m)$35.93M$52.79M(m)
2017-09-30$99.57M(m)$74.84M$24.73M(m)
2017-06-30$108.64M(m)$76.11M$32.54M(m)
2017-03-31$28.89M(m)$6.96M$21.93M(m)
2016-12-31$31.25M(m)$5.51M$25.73M(m)
2016-09-30(m)(m)$4.09M(m)(m)
2016-06-30(m)(m)$5.28M(m)(m)
2016-03-31(m)(m)$4.80M(m)(m)
2015-12-31(m)(m)$8.15M(m)(m)
2014-12-31(m)(m)$4.20M(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.